Cramer: Buying Trea...
Health Care: Health Services
Boston Scientific Inc. (BSX: NYSE)
$5.61 -0.13 | -2.26%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 7.62B | 7.81B | 8.19B | 8.05B |
| Cost of Sales | 2.36B | 2.30B | 2.25B | 2.15B |
| Gross Operating Profit | 5.26B | 5.51B | 5.94B | 5.90B |
| Selling, General, and Administrative Expenses | 2.66B | 2.76B | 4.85B | 2.79B |
| Research & Development | 895.00M | 939.00M | 1.04B | 1.01B |
| Operating Income before D & A (EBITDA) | 1.70B | 1.81B | 52.00M | 2.10B |
| Depreciation & Amortization | 717.00M | 816.00M | 834.00M | 864.00M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income - Net | 749.00M | 234.00M | -23.00M | 192.00M |
| Special Income / Charges | -725.00M | -1.78B | -12.00M | -3.12B |
| Total Income Before Interest Expenses (EBIT) | 923.00M | -670.00M | -901.00M | -1.56B |
| Interest Expense | 281.00M | 393.00M | 407.00M | 468.00M |
| Pre-Tax Income | 642.00M | -1.06B | -1.31B | -2.03B |
| Income Taxes | 201.00M | 2.00M | -283.00M | 5.00M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 441.00M | -1.06B | -1.02B | -2.04B |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 441.00M | -1.06B | -1.02B | -2.04B |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 441.00M | -1.06B | -1.02B | -2.04B |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
1.26B | 829.00M | -929.00M | 959.00M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 441.00M | -1.06B | -1.02B | -2.04B |
| Basic EPS from Continuing Ops. | 0.29 | -0.70 | -0.68 | -1.36 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.29 | -0.70 | -0.68 | -1.36 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.29 | -0.70 | -0.68 | -1.36 |
| Basic Normalized Net Income/Share | 0.83 | 0.54 | -0.62 | 0.64 |
| EPS fr Continuing Ops. | 0.29 | -0.70 | -0.68 | -1.36 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.29 | -0.70 | -0.68 | -1.36 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.29 | -0.70 | -0.68 | -1.36 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.83 | 0.54 | -0.62 | 0.64 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with BSX
- Portfolio NameUser Type
- ProLeon Cooperman - Omega Advi...
- ContributorHealth Care Stocks Bought a...
- Contributor6 Stocks Purchased by Billi...
- Contributor8 Health Care Stocks Inside...
- UserPFE
- ContributorHigh Volume Technicals for ...
- ContributorS&P 500 Stocks With Notable...
- ProBridger Management
- UserWatch List - Healthcare / B...
- UserActual
Latest BSX Headlines from TheStreet
- Boston Scientific's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.19.12 | 01:04 pm
- Oracle, Boston Scientific: David Tepper Takes New Positions 02.24.12 | 11:02 am
- Boston Scientific Bulls Angle for Rebound 02.17.12 | 05:02 am
- 6 Stocks Purchased by Billionaire Tepper Include Oracle, Apple 02.15.12 | 09:02 am
- Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.02.12 | 03:02 pm
- 8 Health Care Stocks Insiders Are Bullish on 12.28.11 | 04:12 pm
- Analysts' Actions: AMZN, BSX, DD, LOW, FSLR 12.15.11 | 09:12 am
- Boston Scientific Stock Hits New 52-Week Low (BSX) 12.12.11 | 12:12 pm
- Boston Scientific Inc. (BSX): Today's Featured Health Care Winner 12.05.11 | 04:12 pm
- 5 Things You Need to Know Before the Stock Market Opens 12.05.11 | 08:12 am
Press Releases for BSX
- Boston Scientific Announces Expanded Indication For CRE Wireguided Balloon Dilator - PR Newswire 05.29.12 | 08:05 am
- PROMUS Element⢠Stent Demonstrates Excellent Long-Term Safety And Effectiveness In PLATINUM Small Vessel Study - PR Newswire 05.18.12 | 04:05 am
- Boston Scientific Announces FDA Approval And U.S. Launch Of EPIC⢠Vascular Stent - PR Newswire 05.17.12 | 05:05 pm
- Boston Scientific Announces U.S. Launch Of Z Flex-270⢠Steerable Sheath - PR Newswire 04.11.12 | 08:04 am
- Boston Scientific To Announce First-Quarter 2012 Financial Results On April 19 - PR Newswire 04.10.12 | 02:04 pm
- Boston Scientific Launches Innovative Device Used To Prevent Stone Migration In Urologic Procedures - PR Newswire 04.02.12 | 08:04 am
- Boston Scientific Supports New Clinical Trial To Evaluate Platinum Chromium Coronary Stents In Treating Heart Attack Patients - PR Newswire 03.26.12 | 08:03 am
- Landmark Analysis Of Year Two Data From PLATINUM Workhorse Trial Demonstrates Superior Efficacy Of PROMUS Element⢠Platinum Chromium Stent Compared To PROMUS® (Xience V®) Stent - PR Newswire 03.25.12 | 12:03 pm
- Analysis Of Two Randomized Clinical Trials Identify No Cases Of Longitudinal Stent Deformation With Boston Scientific Platinum Chromium Stents - PR Newswire 03.25.12 | 12:03 pm
- Boston Scientific Announces New Clinical Data To Be Presented At ACC 2012 On The Market-Leading PROMUS Element⢠Stent - PR Newswire 03.20.12 | 08:03 am
Partner Headlines for BSX
- St. Jude Remains Neutral - Analyst Blog - Zacks 05.25.12 | 03:05 pm
- After Hours Most Active for May 18, 2012 : FB, BAC, QQQ, ARUN, PRIS/B, GE, HSY, WFC, MSFT, INTU, BSX, CSCO - NASDAQ 05.18.12 | 08:05 pm
- Boston Scientific Announces Positive Data from Lotus Transcatheter Aortic Valve Trial - Benzinga 05.15.12 | 12:05 pm
- The Zacks Analyst Blog Highlights: St. Jude Medical, Abbott Laboratories, Medtronic, Boston Scientific and Big Lots - Press Releases - Zacks 04.26.12 | 09:04 am
- ANGO Mixed, Adjusts View - Analyst Blog - Zacks 04.05.12 | 09:04 am
- Medtronic May Rise 30%, Outperforming Peers - Seeking Alpha 03.30.12 | 08:03 am
- Zacks Bull and Bear of the Day Highlights: The Kroger, Dril-Quip, Medtronic, Boston Scientific and St. Jude Medical - Press Releases - Zacks 03.27.12 | 09:03 am
- Positive Data for Medtronic's DES - Analyst Blog - Zacks 03.26.12 | 07:03 pm
- Analyzing Bank Of America's Top 5 Sells - Seeking Alpha 03.22.12 | 08:03 am
- April Stocks To Buy With Covered Calls (ROUND 2) - Seeking Alpha 03.20.12 | 09:03 am
